M. Nucci

Infectious Diseases · 2007–2019

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Nucci trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Romani
  2. M. Pfaller

Who trusts M. Nucci overall

  1. Dennis L. Stevens

Papers from M. Nucci's perspective

Ordered by how strongly the researchers M. Nucci trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Comparison of caspofungin and amphotericin B for invasive candidiasis. (New England Journal of Medicine)
  2. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (Clinical Microbiology Reviews)
  3. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
  4. Attributable mortality of nosocomial candidemia, revisited. (Clinical Infectious Diseases)
  5. Voriconazole treatment for less-common, emerging, or refractory fungal infections. (Clinical Infectious Diseases)
  6. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. (Clinical Infectious Diseases)
  7. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. (Clinical Infectious Diseases)
  8. Immunity to fungal infections (Nature reviews. Immunology)
  9. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. (The Lancet)
  10. European Organization for Research and Treatment of Cancer

Their papers